|
NEWS | SPORTS | OPINION | ARTS | PAGE TWO | FEATURES | FOOD | SCIENCE | COMICS | MEDIA | SPECIAL SECTIONS | RESOURCES |
|
Correction: This article incorrectly stated that R. Alta Charo receives research funding from Wisconsin Alumni Research Foundation. The Cardinal regrets this error.
A UW-Madison professor of law and bioethics was appointed to President-elect Barack Obama’s transition team Friday.
R. Alta Charo, a prominent university researcher who was previously a member of former President Bill Clinton’s Bioethics Advisory Commission, will serve on Obama’s Health and Human Services team.
Charo confirmed her appointment via e-mail, but said she could not provide further comments at this time.
Norman Fost, UW-Madison professor of medicine and public health and a colleague of Charo, said her appointment was due to her nationally and internationally recognized expertise on ethical, legal and policy issues involving health care.
According to Fost, Charo is a well-known advocate for stem cell research. As chair of a National Academy of Sciences Institute of Medicine committee, she plays a leadership role in writing stem cell research guidelines.
Carl Gulbrandsen, managing director of the Wisconsin Alumni Research Foundation, said her appointment speaks well of the university.
“From my perspective, I don’t think they could have chosen anyone better,” Gulbrandsen said. “She’ll do a great job and be a great ambassador for the university.”
For decades Charo has been a longstanding supporter of pro-choice policies and has served as an advisor to the Guttmacher Institute, a national organization involved in reproductive rights, Fost said.
UW-Madison junior Bryon Eagon, state coordinator of Students for Barack Obama, said he believes Charo’s appointment will provide the new administration with insight to the ethics behind stem-cell research.
“Her new position shows that the Obama administration is ready to turn the page on President [George] Bush’s neglect to even explore potential life saving medical advances through embryonic stem cell research,” Eagon said in an e-mail.
Despite attention placed on stem-cell research, once in office, Obama’s number one priority in Health and Human Services will be citizens’ access to health care, Fost said.
“[Obama’s] heart is in the direction [of overturning the stem-cell research ban] but it will be a matter of tactics and strategy as to when or if he takes that on,” he said.
![]() | ![]() |
![]() | ![]() |
![]() |
![]() |
||||||||||||||||||||||||
| Resources | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
![]() |
![]() |
||||||||||||||||||||||||
![]() |
![]() |
|
![]() |
||
![]() |
![]() |
|
NEWS | SPORTS | OPINION | ARTS | PAGE TWO | FEATURES | FOOD | SCIENCE | COMICS | MEDIA | SPECIAL SECTIONS | RESOURCES |
|
All Content Copyright © - The Daily Cardinal Media Corporation | |||||||||